Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome

Neurobiology of Aging
Evangelia EmmanouilidouKostas Vekrellis

Abstract

Proteasomal dysfunction may play a role in neurodegenerative conditions and protein aggregation. Overexpression in neuronal cells of alpha-synuclein, a molecule linked to Parkinson's Disease, may lead to proteasomal dysfunction. Using PC12 cells stably expressing wild-type or mutant alpha-synuclein and gel filtration, we demonstrate that soluble, intermediate size oligomers of alpha-synuclein co-elute with the 26S proteasome. These soluble oligomers associate with the 26S proteasome and are significantly increased following treatment with proteasomal, but not lysosomal, inhibitors, indicating specific degradation of these particular species by the 26S proteasome. Importantly, expression of alpha-synuclein resulted in a significant inhibition of all proteasomal activities without affecting the levels or assembly of the 26S proteasome. Pharmacological dissociation of alpha-synuclein oligomers restored proteasomal function and reduced polyubiquitinated protein load in intact cells. Our findings suggest a model where only a subset of specific soluble cell-derived alpha-synuclein oligomers is targeted to the 26S proteasome for degradation, and simultaneously inhibit its function, likely by impeding access of other proteasomal substr...Continue Reading

References

May 12, 1995·The Journal of Biological Chemistry·I Jariel-EncontreM Piechaczyk
Dec 14, 1995·Biochimica Et Biophysica Acta·T AkaishiH Sawada
Dec 20, 1996·The Journal of Biological Chemistry·L Hoffman, M Rechsteiner
Jun 11, 1998·The Biochemical Journal·K B HendilK Tanaka
Oct 9, 1999·The American Journal of Pathology·D W DicksonS H Yen
Nov 24, 1999·The Journal of Biological Chemistry·M C BennettM M Mouradian
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·V HeiserE E Wanker
May 22, 2001·Archives of Biochemistry and Biophysics·R Hartmann-PetersenK B Hendil
Sep 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·E PaxinouH Ischiropoulos
Jan 29, 2002·Journal of Molecular Biology·Klavs B HendilKeiji Tanaka
Oct 29, 2002·Molecular and Cellular Neurosciences·Hardy J Rideout, Leonidas Stefanis
Dec 10, 2002·Experimental Gerontology·A Jennifer RivettKatia Forti
Jan 29, 2003·The Journal of Biological Chemistry·Heather SnyderBenjamin Wolozin
Apr 4, 2003·The International Journal of Biochemistry & Cell Biology·Kenneth J Rodgers, Roger T Dean
Apr 30, 2003·The Journal of Biological Chemistry·Julie L WebbDavid C Rubinsztein
Nov 1, 2003·Science·A B SingletonK Gwinn-Hardy
Dec 16, 2003·The Journal of Biological Chemistry·Hideyuki SawadaShun Shimohama
Jan 9, 2004·The Journal of Biological Chemistry·Evo LinderssonPoul H Jensen
Feb 3, 2004·Annals of Neurology·Matt FarrerJ William Langston
Feb 7, 2004·Cell Death and Differentiation·O JabadoL Stefanis
Feb 27, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·He-Jin LeeSeung-Jae Lee
Mar 3, 2004·Nature Reviews. Molecular Cell Biology·Cecile M Pickart, Robert E Cohen
Mar 27, 2004·The Journal of Biological Chemistry·Jochen KluckenPamela J McLean

❮ Previous
Next ❯

Citations

Jun 30, 2012·Acta Neuropathologica·Darius Ebrahimi-FakhariPamela J McLean
Jan 24, 2009·Apoptosis : an International Journal on Programmed Cell Death·Oren A LevyLloyd A Greene
Oct 12, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Dawn BéraudKathleen A Maguire-Zeiss
Sep 1, 2012·Molecular Neurobiology·Toru YasudaHideki Mochizuki
Sep 4, 2012·Molecular Neurobiology·Maria XilouriLeonidas Stefanis
Mar 1, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Shubhangi PrabhudesaiJeff M Bronstein
May 14, 2011·Cell Death and Differentiation·J A SteinerP Brundin
Feb 23, 2012·Cold Spring Harbor Perspectives in Medicine·Leonidas Stefanis
May 4, 2012·Cold Spring Harbor Perspectives in Medicine·Casey CookLeonard Petrucelli
Mar 10, 2010·Biochemistry. Biokhimii︠a︡·A V SorokinL P Ovchinnikov
Feb 6, 2009·Molecular Neurodegeneration·Mark R Cookson
Dec 10, 2013·Acta Neuropathologica Communications·Darius Ebrahimi-FakhariLara Wahlster
May 21, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Evangelia EmmanouilidouKostas Vekrellis
Jun 3, 2014·BMC Systems Biology·Eleftherios OuzounoglouElias S Manolakos
Nov 30, 2014·Neurologic Clinics·Stephen Mullin, Anthony H V Schapira
Jan 21, 2014·Antioxidants & Redox Signaling·Chris McKinnon, Sarah J Tabrizi
Jun 12, 2009·PloS One·Casey CookLeonard Petrucelli
Feb 9, 2016·Experimental Neurology·Stephanie M FogersonJennifer R Morgan
Mar 31, 2015·Biomolecules·Hazel L Roberts, David R Brown
Sep 24, 2014·Proceedings of the National Academy of Sciences of the United States of America·George H GorrieHan-Xiang Deng
Apr 14, 2011·Journal of Neuropathology and Experimental Neurology·Anne-Laure J MougenotThierry G Baron
Apr 26, 2016·Oxidative Medicine and Cellular Longevity·Dolores Limongi, Sara Baldelli
Jul 21, 2015·Journal of Neurochemistry·Anna Villar-PiquéTiago Fleming Outeiro
Mar 4, 2015·Brain : a Journal of Neurology·Rosalind F RobertsJavier Alegre-Abarrategui
Mar 29, 2012·Prion·Ralph Andre, Sarah J Tabrizi
Mar 18, 2015·Acta Neuropathologica·Marcel KunadtAnja Schneider
Mar 21, 2015·Biochimica Et Biophysica Acta·Zhi TangJin-Jing Pei
Aug 2, 2014·European Journal of Medicinal Chemistry·Omid TavassolyJeremy S Lee
Jan 24, 2014·Metallomics : Integrated Biometal Science·Julia BornhorstMichael Aschner
May 12, 2016·Ageing Research Reviews·Julia K GötzlAnja Capell
Jul 23, 2014·Neurobiology of Disease·Juan F ReyesPatrik Brundin
Aug 23, 2016·Chemical Communications : Chem Comm·Thomas SchraderFrank-Gerrit Klärner
Feb 8, 2018·Cell and Tissue Research·Veselin Grozdanov, Karin M Danzer
Dec 31, 2014·Experimental Neurobiology·Abid OueslatiKostas Vekrellis
Mar 17, 2018·Nature Communications·Tiffany A ThibaudeauDavid M Smith
May 16, 2009·Neurochemical Research·Su Ling LeongChi Le Lan Pham
Apr 21, 2019·Journal of Neurochemistry·Amir Tayaranian MarvianTiago Fleming Outeiro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.